Oral Immunotherapy

SAN DIEGO — Household composition and family history influenced concerns and knowledge about pediatric food allergy among expectant mothers, according to a presentation here.

SAN DIEGO — Patients with three different food allergies who used omalizumab experienced better outcomes than patients who used multi-food oral immunotherapy, driven by lower rates of adverse events, according to an abstract presented here.

Healio spoke with an expert about their study of U.S. and Canadian patients who had anaphylaxis to insect stings between 2010 and 2023, which revealed that those taking lipid-lowering medications experienced more severe reactions.

Following receipt of increasing peanut oral immunotherapy, or home-measured peanut butter, desensitization to peanut protein in children initially able to ingest more than half a peanut was achieved, according to study results.

Caregivers of children with food allergy among minoritized racial and ethnic groups were less familiar with oral immunotherapy than caregivers of non-Hispanic white children with food allergy, according to a recent study.

The field of food allergy treatment has been evolving rapidly, with several promising developments in recent years. Typically, much of what makes headlines, though, surrounds who pays for the headlines.

The ADAPT OIT program builds peanut tolerance in babies with daily dosing of peanut powder administered by caregivers at home, according to a National Allergy Centre of Excellence and Murdoch Children’s Research Institute press release.

The FDA has approved Palforzia, an oral immunotherapy designed to protect children aged 1 to 3 years with peanut allergies from reactions caused by accidental exposure, according to a press release.

The FDA has approved Palforzia for children aged 1 to 3 years who have a peanut allergy that has been diagnosed by a physician, according to a press release from its manufacturer, Stallergenes Greer.

A recent study found that health care professionals were increasingly able to identify infants and young children with anaphylaxis by following modified criteria.